Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

DOCKweb: a web-based GUI platform for molecular modeling with DOCK6.

Created on 06 Jul 2026

Authors

Steven Pak, Brock T Boysan, William J Allen, Robert C Rizzo

Published in

Journal of computer-aided molecular design. Volume 40. Issue 1. Jul 06, 2026. Epub Jul 06, 2026.

Abstract

Virtual screening (VS) and de novo design (DN) are powerful computational approaches used to identify and refine potential drug-lead candidates against clinically relevant targets. However, many software programs used for VS and DN, including our codebase DOCK6, can be difficult to use and deploy for users lacking experience with command-line environments. To make such tools easier to use, we are developing a full-stack web application, termed DOCKweb, to help streamline the DOCK6 experience for users of all skill levels. As outlined in this work, we employed web-based tools such as React.js and Express.js to develop an online interactive graphical user-interface (GUI), streamlining key setup procedures and submission of DOCK6 calculations. Importantly, the DOCKweb GUI eliminates the need for users to download and compile their own version of the program. Further, calculations submitted through DOCKweb are currently executed at the Texas Advanced Computer Center (TACC) which removes the requirement that users need access to a local supercomputer.

PMID:
42406155
Bibliographic data and abstract were imported from PubMed on 06 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement